CareCentrix to manage network for independent home infusion therapy and ambulatory infusion suite providers, starting Jan. 1

Effective Jan. 1, 2022, Blue Cross Blue Shield of Michigan and Blue Care Network will delegate management of the in-state independent home infusion therapy and ambulatory infusion suite provider network to CareCentrix for commercial members.

This change won’t affect:

• Hospital-owned home infusion therapy or ambulatory infusion suite providers
• Members with Medicare Plus Blue℠ or BCN Advantage℠ plans

CareCentrix is a leader in managing infusion therapy services. It manages a national network of more than 800 home infusion therapy and ambulatory infusion suite providers.

We expect the transition to CareCentrix to improve member care through better management of home infusion therapy and ambulatory infusion suite services.

Note: Ambulatory infusion suites are a subset of ambulatory infusion centers.

Here’s what affected providers need to do

1. If you aren’t already contracted with CareCentrix, contract with them as soon as possible and before Jan. 1, 2022. This will allow you to continue to provide in-network services to Blue Cross commercial and BCN commercial members. You’ll receive a letter from CareCentrix that outlines the steps you’ll need to take.
   
   If you’re already contracted with CareCentrix, you don’t need to do anything. Your CareCentrix contract manager will reach out to you to discuss this change.


2. For services provided in Michigan to Blue Cross and BCN commercial members on or after Jan. 1, 2022, independent home infusion therapy and ambulatory infusion suite providers who are contracted with CareCentrix must bill CareCentrix.
   
   Don’t bill Blue Cross or BCN for home infusion therapy and ambulatory infusion suite services; Blue Cross and BCN will reject these claims with a message to bill CareCentrix.

Note: Independent home infusion therapy and ambulatory infusion suite providers can continue to bill Blue Cross and BCN for services provided to Medicare Advantage members and for other services, such as providing durable medical equipment and supplies. These services aren’t affected by this change.

We’ll end-date all Blue Cross and BCN independent home infusion therapy and ambulatory infusion suite contracts for commercial coverage, effective Dec. 31, 2021.

Who this change applies to

This change applies to independent HIT and AIS providers who:

• Participate with Blue Cross and BCN
• Aren’t owned by a hospital system
• Provide home infusion services to Blue Cross commercial and BCN commercial members in Michigan

This change doesn’t apply to hospital-owned HIT and AIS providers.

We’ll notify all non-hospital-owned HIT and AIS providers of this change by mail. We’ll also send letters to members who may be affected by this change, and we’ll work with CareCentrix to ensure that there are no gaps in care.

Questions?

To learn more, see this document.

If you have questions about provider contracting, email CareCentrix at homeinfusion@carecentrix.com.